According to Report, the global catheter stabilization devices market size is expected to be worth around USD 2.68 billion by 2030.
The global catheter stabilization devices market size was valued at USD 1.50 billion in 2020 and is projected to grow at a CAGR of 7.8% during the forecast period 2021 to 2030.
Increasing usage of catheters, growing demand for minimally invasive surgeries, increasing prevalence of lifestyle-related diseases, rising number of surgeries being performed, and population aging are key contributors to market growth.
Intravascular catheters have become an essential part of patient care in hospitals and other healthcare settings. According to the Joint Commission, 3 million central venous catheters (CVC) are used in the U.S. each year and around 250,000 CVCs are used in the UK annually. However, the rising use of catheters increases the risk of bloodstream infections related to its usage. Dislodgement, migration, accidental removal, or occlusion of catheters may lead to infections and complications and may pose a risk to patient safety. Thus, the surging number of catheter placements is one of the key contributors to the growth of this market.
Growing awareness among healthcare professionals and the increasing need to reduce the burden of catheter-associated infections are also expected to boost the adoption of stabilization devices. Catheter securement is crucial for reducing related infections & complications and thus, is gaining significance in patient care. Various national and government organizations, such as CDC, Australia, and New Zealand Urological Nurses Society (ANZUNS), and Occupational Safety and Health Administration (OSHA), issue guidelines that recommend the use of securement devices in the treatment of patients.
In 2020, the arterial securement devices segment held the largest share in the market. Arterial catheters are frequently used worldwide in routine modern healthcare practices. This segment held the majority of the market share owing to the extensive use of arterial catheters in a large number of surgeries associated with cardiovascular diseases and cancer therapies. The wide use of these devices makes securement important to reduce complications associated with their use.
Arterial catheters are widely used for interventions in ICUs globally. Rhode Island Medical Journal in its August 2014 issue stated that an estimated 6 million arterial catheters are placed in the U.S. each year. According to the Australian Vascular Access Society, up to 25% of the arterial catheters fail during treatment owing to dislodgement, accidental removal, occlusion, or infection.
The CVC securement devices segment is expected to grow at the fastest rate with a CAGR of 7.5% during the forecast period. CVC securement is gaining importance owing to benefits such as the absence of interruptions during treatments, few repeat procedures & reinsertions, and a decrease in CVC replacement costs. An effective securement is crucial for critically ill patients requiring long-term therapy such as in the case of cancer.
In 2020, the hospital segment held the majority of the share. A high number of surgeries are being performed in hospitals. Catheters have been widely used in hospitals for various kinds of treatments. The prevalence of infections associated with their usage is high in hospitalized patients. Catheter-Associated Urinary Tract Infections (CAUTI) are the most commonly reported hospital-acquired infections and their prevalence continue to increase.
According to American Nurses Association (ANA), more than 560,000 patients acquire CAUTI every year. Hospital-acquired infections are one of the major threats to patient safety and the American Journal of Infection Control estimates that these infections cost around USD 33 billion. Thus, the growing prevalence of infections in hospitals contributes to the large share held by this segment.
The hospitals segment is also expected to continue its dominance with the fastest growth rate over the forecast period. Improving healthcare services in developing regions and the increasing number of hospitals globally is expected to contribute to the growing usage of stabilization devices.
North America dominated the catheter securement devices market in 2020 with the highest revenue share. The large share of this region can be attributed to the high number of surgeries, which leads to an increase in the demand for stabilization devices Wide adoption of catheterization techniques in examination, diagnosis, and treatment is also one of the factors responsible for catheter securement device market growth. Increasing usage of intravascular catheters in this region is further anticipated to drive the market.
The U.S. is the largest market in this region and across the globe due to the increase in the number of catheter placements. According to the Joint Commission, an estimated 300 million catheters are used each year in the U.S. of which nearly 3 million are central venous. High prevalence of CLABSIs and CAUTIs increases the need to curb these infections, which is anticipated to drive the market.
The Asia Pacific is expected to exhibit the fastest growth over the next few years owing to a large patient pool, growing target population, high unmet needs, and improving infrastructure in the region. Growing demand for various surgeries, improving healthcare facilities, and increasing awareness among the public and professionals are expected to boost growth in this region.
Some of the significant players are C.R. Bard, Inc.; Baxter; 3M, Centurion Medical Products; B Braun Melsungen AG; Merit Medical Systems, Inc.; ConvaTec, Inc.; TIDI Products, LLC; and Smiths Medical.
Arterial Securement Devices
Central Venous Catheter Securement Devices
Peripheral Securement Devices
Urinary Catheter Securement Devices
Chest Drainage Tube Securement Devices
Other Securement Devices
Middle East & Africa
Retinal Disorders Treatment Market (By Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; By Therapeutic Class; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...